Genomics

New submissions

• New submissions

New submissions for Wed, 22 Mar 23

[1]  arXiv:2303.11336 [pdf, other]

Title: Studying Limits of Explainability by Integrated Gradients for Gene Expression Models

Authors: Myriam Bontonou, Anaïs Haget, Maria Boulougouri, Jean-Michel Arbona, Benjamin Audit, Pierre Borgnat

Subjects: Genomics (q-bio.GN); Machine Learning (cs.LG)

Understanding the molecular processes that drive cellular life is a fundamental question in biological research. Ambitious programs have gathered a number of molecular datasets on large populations. To decipher the complex cellular interactions, recent work has turned to supervised machine learning methods. The scientific questions are formulated as classical learning problems on tabular data or on graphs, e.g. phenotype prediction from gene expression data. In these works, the input features on which the individual predictions are predominantly based are often interpreted as indicative of the cause of the phenotype, such as cancer identification. Here, we propose to explore the relevance of the biomarkers identified by Integrated Gradients, an explainability method for feature attribution in machine learning. Through a motivating example on The Cancer Genome Atlas, we show that ranking features by importance is not enough to robustly identify biomarkers. As it is difficult to evaluate whether biomarkers reflect relevant causes without known ground truth, we simulate gene expression data by proposing a hierarchical model based on Latent Dirichlet Allocation models. We also highlight good practices for evaluating explanations for genomics data and propose a direction to derive more insights from these explanations.

[2]  arXiv:2303.11695 [pdf, other]

Title: Transcriptomics-based matching of drugs to diseases with deep learning

Authors: Yannis Papanikolaou, Francesco Tuveri, Misa Ogura, Daniel O'Donovan

Subjects: Genomics (q-bio.GN); Machine Learning (cs.LG)

In this work we present a deep learning approach to conduct hypothesis-free, transcriptomics-based matching of drugs for diseases. Our proposed neural network architecture is trained on approved drug-disease indications, taking as input the relevant disease and drug differential gene expression profiles, and learns to identify novel indications. We assemble an evaluation dataset of disease-drug indications spanning 68 diseases and evaluate in silico our approach against the most widely used transcriptomics-based matching baselines, CMap and the Characteristic Direction. Our results show a more than 200% improvement over both baselines in terms of standard retrieval metrics. We further showcase our model's ability to capture different genes' expressions interactions among drugs and diseases. We provide our trained models, data and code to predict with them at https://github.com/healx/dgem-nn-public.

• New submissions